Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Investor profile

Casdin Capital

Venture capital firm · Founded 2012 · Active in 2026

Casdin Capital is a venture capital firm based in USA, founded in 2012. The page below shows 52 Power Law outcomes from Casdin Capital's portfolio — 37 unicorns ($1B+ valuation) and 4 additional thoroughbreds (companies that crossed $100M+ in revenue without yet reaching $1B+ valuation).

Outcomes are concentrated in Biotech & Life Sciences · Health Tech & Medtech · Transportation; top portfolio geographies are USA · UK · China. Casdin ranks #388 in Global in the 2026 Dealroom Power Law Investor Ranking by cross-stage outcomes.

52 Power Law outcomes Power Law Ranking #388 · Global · 52 Power Law outcomes · Active 2026
Unicorns ↑ 32% 5y
37
Decacorns ↑ 200% 5y
3
Thoroughbreds ↑ 67% 5y
14
01 · Exits

Sequoia’s biggest exits.

Sequoia portfolio companies worth $1B+ that have IPO’d or been acquired. Each shows its valuation at exit and, in grey, its current value if still public.

IPO · 1999
Entered SeedNow $5.2T
IPO · 2004
Entered Series ANow $4.6T
IPO · 1980
Now $4.5T
IPO · 2014
Entered Series B+Now $306B
$214B IPO · 2021
Entered Series B+Now $20.1B
IPO · 2012
Entered Series ANow $207B
$82.0B IPO · 2019
Now $153B
IPO · 2012
Entered Series B+Now $103B
$95.0B IPO · 2020
Entered SeedNow $69.1B
$93.9B IPO · 2020
Entered Series B+Now $58.4B
$24.0B IPO · 2018
Entered Series B+Now $73.3B
$39.0B IPO · 2020
Entered Series ANow $67.6B
$32.0B IPO · 2021
Entered Series B+Now $67.5B
$41.5B IPO · 2021
Entered SeedNow $64.4B
$60.0B IPO · 2021
Entered Series B+Now $28.0B
$55.5B IPO · 2026
Entered Series B+Now $55.5B
$52.8B IPO · 2018
Entered Series ANow $49.6B
IPO · 2013
Now $45.0B
IPO · 2015
Entered Series B+Now $39.4B
IPO · 2002
Entered SeedNow $39.1B
$32.0B acquisition · 2025
Entered Seed
$12.0B IPO · 2021
Entered Series B+Now $29.5B
IPO · 2014
Entered Series B+Now $28.6B
IPO · 2015
Entered Series ANow $28.2B
03 · Portfolio analysis

The 52 Casdin Power Law outcomes ($100M+ revenue or $1B+ valuation).

Snapshot of where the outcomes are concentrated by country, sector, and stage entered.

By countryCount
  1. USA48
  2. UK2
  3. China1
  4. South Korea1
By sectorCount
  1. Biotech & Life Sciences47
  2. Health Tech & Medtech4
  3. Transportation1
By stage enteredCount
  1. Series B+30
  2. Series A10
Estimated holdings

Casdin’s biggest current holdings.

An estimate of Casdin’s largest live positions — disclosed shareholding × Dealroom’s latest valuation — across 1 companies where Casdin is a named shareholder, worth about $105M in estimated equity value.

#CompanyEst. stakeValuationEst. value
  1. 1 LetsGetCheckedHealth · Unicorn 10.5% $1.0B $105M

Estimated value = Casdin’s disclosed ownership % × Dealroom’s latest company valuation; direct named stakes only, exited positions excluded. Figures are indicative, not reported marks. Casdin also appears inside investor groups in Lyra Health, where a standalone stake isn’t disclosed. See the underlying cap tables on Dealroom →

Casdin’s biggest exits.

Casdin portfolio companies worth $1B+ that have IPO’d or been acquired. Each shows its valuation at exit and, in grey, its current value if still public.

$1.4B IPO · 2020
Entered Series B+Now $30.5B
$2.0B IPO · 2019
Now $15.1B
IPO · 2015
Entered Series ANow $13.1B
$630M IPO · 2020
Entered Series B+Now $12.0B
IPO · 2015
Entered Series B+Now $8.2B
$5.4B IPO · 2021
Entered Series B+Now $1.5B
IPO · 2013
Entered Series B+Now $5.3B
$3.5B IPO · 2021
Now $150M
$2.9B IPO · 2021
Entered Series B+Now $688M
$2.7B IPO · 2021
Entered Series B+Now $1.0B
$167M IPO · 2021
Entered Series B+Now $2.6B
$1.7B IPO · 2020
Entered Series B+Now $2.3B
$2.2B acquisition · 2020
Entered Series A
$2.0B IPO · 2021
Now $2.0B
$150M IPO · 2018
Entered Series B+Now $1.7B
$1.5B acquisition · 2025
Entered Series A
$1.5B acquisition · 2021
Entered Series B+
$1.4B IPO · 2021
Entered Series B+Now $674M
$157M IPO · 2020
Entered Series B+Now $1.4B
$1.3B IPO · 2021
Now $255M
$1.3B IPO · 2019
Entered Series B+Now $75M
IPO · 2015
Now $1.3B
$366M IPO · 2022
Entered Series B+Now $1.2B
$1.2B IPO · 2021
Entered Series B+Now $1.2B

+3 more $1B+ exits on the full Dealroom profile.

04 · Portfolio market map

Casdin's 52 Power Law outcomes.

Stage entered
Outcome tier
Region
Group by
52 of 52 Power Law outcomes
05 · Power Law comparison

How does Casdin stack up?

Casdin in orange, your selection in blue and other colours. Pick from the global roster of 609 peer investors — scope by startup location or hit "Find similar shapes" to auto-pick the three closest. The funnel matrix mirrors the spider chart on the ranking page; the line chart shows each firm's share of unicorns minted in the selected startup location — peaks reveal vintage years.

Compare against

Share of new unicorns per year

% of global unicorns minted that year, year by year · hover the chart to see which unicorns
Performance window All-time → 2026

Stage focus

Companies by selected outcome stage

Sector focus

Companies per investor across the 10 highest-volume sectors

Beyond Unicorns — how the portfolio compounds

% of each investor's unicorn portfolio that later crossed $10B, $25B and $50B. Pick a sort tier and entry stage.
Sort by
Entry stage
Source: Dealroom Power Law dataset. Investors shown are the 2026 Power Law top 35 by combined entry-to-outcome score, drawn from the overview and locations_data sheets. Funnel-matrix axes rescale per-axis using the maximum among the currently selected investors, so the polygons always fill the chart for shape comparison.
06 · Portfolio founders

Where Sequoia's portfolio founders come from — and where they studied.

161 founders across the 52 Power Law outcomes — split by country of origin, university attended, and the company they worked at before founding. Korea Advanced Institute of Science and Technology and Apple are the deepest single pipelines.

LocationCount
United States101
South Korea12
India4
Taiwan4
China3
United Kingdom3
Germany2
Italy2
Sweden1
Israel1
+1 more →
UniversityCount
Korea Advanced Institute of Science and Technology10
Harvard University10
Massachusetts Institute of Technology6
The University of Chicago5
Yale University5
Stanford University5
Harvard Medical School4
University of Oxford3
University of Cambridge3
UCLA3
+48 more →
Origin companyCount
Apple3
Flatiron Health2
Microsoft2
Castlight Health2
Beam Therapeutics2
Onyx Pharmaceuticals2
Moderna Therapeutics2
Salesforce2
EQRx2
TMON1
+43 more →
Origin = country a founder is born in or grew up in (founders may have multiple origins; counts include all entries). University = highest-listed degree. Origin company = a previous employer where the founder was tagged before starting their current company.

Market sentiment

What the market is saying about Casdin Capital

An AI-synthesized read of the highest-engagement posts about Casdin on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

In the news

Latest news about Casdin Capital

Recent press, funding announcements, and portfolio moves mentioning Casdin — pulled live from Dealroom's news feed.

See all news

Want the full picture on Casdin Capital?

The Dealroom platform tracks every round, every co-investor, and every portfolio company in real time — across 25,000+ investors and 3M+ companies globally.